Skip to main content

XBRANE · Xbrane Biopharma AB · Financials

11.45 SEK -0.25 (-2.14%) At close · Nov 13
Market Cap
235.93M SEK
Shares
20.61M
Volume · Nov 13 53.8K Avg daily vol (3M) 93.89K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
152.35M +2.9%
FY2025 Revenue FY2021–FY2025
Net Income
127.24M +147.8%
FY2025 Net Income FY2020–FY2025
Gross Margin
58.77% -28.9pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
-18.54% +47.1pp
FY2025 Operating Margin FY2021–FY2025
Operating Cash Flow
-250.69M -87.5%
FY2025 Operating Cash Flow FY2020–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
SEK 152.35M 148.1M 238.73M 57.62M 10.71M —
SEK 62.81M 18.23M 203.34M 0 — —
SEK 89.55M 129.87M 35.39M 57.62M 10.71M —
SEK 117.87M 162.01M 305.78M 199.65M 160.62M 197.28M
SEK 43.82M 40.81M 40.03M 31.54M 31.4M 26.51M
SEK -28.25M -97.22M -322.16M -166.22M -180.58M -217.44M
SEK 16.4M 33M 2.27M 2.3M 2.64M —
SEK -43.93M -129.72M -322.03M -168.51M -183.23M -218.13M
SEK — 11.59M 0 0 0 —
SEK 127.24M -266.22M -388.17M -172.51M -188.38M -226.03M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current borrowings, including current portion of noncurrent borrowings 2025-12-31 SEK 0 ESEF Annual Report filed 2026-10-26
Current lease liabilities 2025-12-31 SEK 0 ESEF Annual Report filed 2026-10-26
Noncurrent lease liabilities 2025-12-31 SEK 0 ESEF Annual Report filed 2026-10-26
Noncurrent long-term borrowings 2025-12-31 SEK 58,308,000 ESEF Annual Report filed 2026-10-26
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.